Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $52.0 million.

  • Verastem's Operating Expenses rose 4031.06% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.6 million, marking a year-over-year increase of 5140.35%. This contributed to the annual value of $125.0 million for FY2024, which is 3569.78% up from last year.
  • According to the latest figures from Q3 2025, Verastem's Operating Expenses is $52.0 million, which was up 4031.06% from $45.9 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Operating Expenses peaked at $52.0 million during Q3 2025, and registered a low of $14.8 million during Q3 2021.
  • For the 5-year period, Verastem's Operating Expenses averaged around $25.9 million, with its median value being $20.8 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 7666.51% in 2021, then surged by 7377.63% in 2024.
  • Verastem's Operating Expenses (Quarter) stood at $17.1 million in 2021, then dropped by 1.23% to $16.8 million in 2022, then rose by 26.49% to $21.3 million in 2023, then skyrocketed by 48.25% to $31.6 million in 2024, then skyrocketed by 64.47% to $52.0 million in 2025.
  • Its Operating Expenses stands at $52.0 million for Q3 2025, versus $45.9 million for Q2 2025 and $44.2 million for Q1 2025.